|
Mutation Information
|
Mutation Site
|
Y135F |
|
Mutation Type
|
Amino acid level |
|
Gene/Protein/Region Type
|
RT |
|
Genotype/Subtype
|
D |
Literature Information
|
PubMed PMID
|
16197491
|
|
Disease
|
Chronic hepatitis B
|
|
Published Year
|
2005 |
|
Journal
|
Alimentary pharmacology & therapeutics |
|
Title
|
Clinical reactivation during lamivudine treatment correlates with mutations in the precore/core promoter and polymerase regions of hepatitis B virus in patients with anti-hepatitis B e-positive chronic hepatitis. |
|
Author
|
Marrone A,Zampino R,Karayannis P,Cirillo G,Cesaro G,Guerrera B,Ricciotti R,del Giudice EM,Utili R,Adinolfi LE,Ruggiero G |
|
Evidence
|
Y135S was detected in eight of eight (100%) in group A and in two of nine (22%) in group B1 (P = 0.001), while Y135F was revealed in zero of eight of group A and in four of five (80%) of group B1 (P = 0.006).
|
|
|
HBV Mutation Detail Information